Linda J. Metheny-Barlow, Ph.D., Assistant Professor Radiation Oncology-Radiation Biology

Linda J. Metheny-Barlow, Ph.D.

Assistant Professor, Radiation Oncology
Comprehensive Cancer Center
Brain Tumor Center of Excellence
Cancer Biology

Contact Information

Academic: 336-713-7636 | Department: 336-713-3600

Email: lmetheny@wakehealth.edu

Education & Training

Ph.D., University of Rochester , 1996
B.S., Wheeling Jesuit College , 1991
M.S., University of Rochester , 1994
Fellowship, Natl Cancer Institute (NIH), 1999
Fellowship, Georgetown University, 2004

Memberships

Am Assn Of Cancer Research
Radiation Research Society

Linda J. Metheny-Barlow, Ph.D.

Assistant Professor, Radiation Oncology Comprehensive Cancer Center
Brain Tumor Center of Excellence
Cancer Biology

Research Interests

cancer/oncogenesis, cell growth, differentiation,d, molecular biology/molecular me, women's health issues

Contact Information

Academic: 336-713-7636 | Department: 336-713-3600

Email: lmetheny@wakehealth.edu

Recent Publications

Barlow KD, Sanders AM, Soker S, Ergun S, Metheny-Barlow LJ. Pericytes on the tumor vasculature: Jekyll or Hyde?. Cancer Microenviron. 2013;6(1):1-17.

Vincent A, Lesser G, Brown D, Vern-Gross T, Metheny-Barlow L, Lawrence J, Chan M. Prolonged regression of metastatic leptomeningeal breast cancer that has failed conventional therapy: a case report and review of the literature. J Breast Cancer. 2013;16(1):122-126.

Buchanan CF, Szot CS, Wilson TD, Akman S, Metheny-Barlow LJ, Robertson JL, Freeman JW, Rylander MN. Cross-talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro. J Cell Biochem. 2012;113(4):1142-1151.

Arter AA, Metheny-Barlow L, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits proliferative and fibrotic signaling mechanisms in triple negative breast cancer [abstract]. In: Proceedings of the 103rd Annual Meeting of the Amerian Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, Illinois. Philadelphia (PA): AACR. 2012;():Abstr 5224.

Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL [deceased], Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol. 2012;110(3):381-388.

Cook KL, Metheny-Barlow LJ, Tallant EA, Gallagher PE. Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors. Cancer Res. 2010;70(21):8319-8328.